These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33028492)

  • 21. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective gastric acid suppression after oral administration of enteric-coated omeprazole granules.
    Mohiuddin MA; Pursnani KG; Katzka DA; Gideon RM; Castell JA; Castell DO
    Dig Dis Sci; 1997 Apr; 42(4):715-9. PubMed ID: 9125637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properties of the reversible, K(+)-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. II. Pharmacological properties.
    Parsons ME; Rushant B; Rasmussen TC; Leach C; Ife RJ; Postius S; Pope AJ
    Biochem Pharmacol; 1995 Nov; 50(10):1551-6. PubMed ID: 7503756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and absorption of the anticancer agents dasatinib and GDC-0941 under various gastric conditions in dogs--reversing the effect of elevated gastric pH with betaine HCl.
    Pang J; Dalziel G; Dean B; Ware JA; Salphati L
    Mol Pharm; 2013 Nov; 10(11):4024-31. PubMed ID: 23980865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.
    Thomson AB; Keelan M; Lastiwka R; Appelman-Eszczuk S; Zuk L; Drozdowski L; Prentice A; Sinclair P
    Dig Dis Sci; 2003 Oct; 48(10):2045-56. PubMed ID: 14627354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-administration of a nanosuspension of a poorly soluble basic compound and a solution of a proton pump inhibitor--the importance of gastrointestinal pH and solubility for the in vivo exposure.
    Sigfridsson K; Lundqvist A; Strimfors M
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1036-42. PubMed ID: 21417620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of HSP72 in the gastric mucosa is regulated by gastric acid in rats-correlation of HSP72 expression with mucosal protection.
    Wada I; Otaka M; Jin M; Odashima M; Komatsu K; Konishi N; Matsuhashi T; Horikawa Y; Ohba R; Itoh H; Watanabe S
    Biochem Biophys Res Commun; 2006 Oct; 349(2):611-8. PubMed ID: 16945336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical and pharmacological characteristics of a newly synthesized H+/K+-ATPase inhibitor, YJA20379-8, 3-butyryl-4-[R-1-methylbenzylamino]-8-ethoxy-1,7-naphthyridine, in pigs and rats.
    Sohn SK; Chang MS; Choi WS; Chung YK; Kim KB; Woo TW; Lee SB; Park CJ
    J Pharm Pharmacol; 1999 Dec; 51(12):1359-65. PubMed ID: 10678489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
    Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
    J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of Single-Dose Ougan Juice Application on the Pharmacokinetics of Erlotinib.
    Yang JZ; Song Y; Xiong JH; Lin YX; Wen C; Li Y; Zhou Y
    Biomed Res Int; 2021; 2021():6679082. PubMed ID: 34195278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organic Anion Transporting Polypeptide (OATP)2B1 Contributes to Gastrointestinal Toxicity of Anticancer Drug SN-38, Active Metabolite of Irinotecan Hydrochloride.
    Fujita D; Saito Y; Nakanishi T; Tamai I
    Drug Metab Dispos; 2016 Jan; 44(1):1-7. PubMed ID: 26526067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Osmolality on the Pharmacokinetic Interaction between Apple Juice and Atenolol in Rats.
    Funai Y; Shirasaka Y; Ishihara M; Takemura M; Ichijo K; Kishimoto H; Inoue K
    Drug Metab Dispos; 2019 Apr; 47(4):386-391. PubMed ID: 30622163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of NC-1300 and its degradation products on gastric secretion and HCl.ethanol-induced gastric lesions in rats.
    Okabe S; Akimoto Y; Miyake H; Imada J
    Jpn J Pharmacol; 1987 May; 44(1):7-14. PubMed ID: 3626185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of concurrent acid-suppression therapy with survival outcomes and adverse event incidence in oncology patients receiving erlotinib.
    Lam LH; Capparelli EV; Kurzrock R
    Cancer Chemother Pharmacol; 2016 Aug; 78(2):427-32. PubMed ID: 27372908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of thyrotropin-releasing hormone (TRH) in the pathogenesis of water-immersion stress in rats--inhibition of TRH release from the stomach by atropine, ranitidine or omeprazole.
    Uchida K; Mitsuma T; Morise K; Kaneko H; Nagai H; Furusawa A; Nakada K; Maeda Y
    Gastroenterol Jpn; 1993 Feb; 28(1):1-9. PubMed ID: 8095031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of YJA20379-4 on gastric secretion, Helicobacter pylori growth and various gastric and duodenal lesions in rats.
    Woo TW; Chang MS; Chung YK; Kim KB; Sohn SK; Kim SG; Choi WS
    Biol Pharm Bull; 1998 May; 21(5):449-55. PubMed ID: 9635498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia-reperfusion into gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Drozdowicz D; Kwiecieñ S; Pajdo R; Bielanski W; Hahn EG
    Eur J Pharmacol; 2000 Jun; 398(1):147-58. PubMed ID: 10856459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of omeprazole on changes in gastric and upper small intestine pH levels in patients with chronic pancreatitis.
    Nakamura T; Arai Y; Tando Y; Terada A; Yamada N; Tsujino M; Imamura K; Machida K; Kikuchi H; Takebe K
    Clin Ther; 1995; 17(3):448-59. PubMed ID: 7585849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton pump inhibitors: better acid suppression when taken before a meal than without a meal.
    Hatlebakk JG; Katz PO; Camacho-Lobato L; Castell DO
    Aliment Pharmacol Ther; 2000 Oct; 14(10):1267-72. PubMed ID: 11012470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of L-lactic acid on calcium absorption in rats fed omeprazole.
    Chonan O; Takahashi R; Yasui H; Watanuki M
    J Nutr Sci Vitaminol (Tokyo); 1998 Jun; 44(3):473-81. PubMed ID: 9742467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.